Routine Blood Test Identifies Laboring Women at Risk for Preeclampsia
A blood test measuring the fibrinogen-to-albumin ratio can predict the risk of preeclampsia in laboring women, improving maternal outcomes.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Womens Health |
A blood test measuring the fibrinogen-to-albumin ratio can predict the risk of preeclampsia in laboring women, improving maternal outcomes.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Unknown Origin & Other Cancer Types |
Thermo Fisher’s CDx for identifying glioma patients eligible for treatment with Servier Pharmaceuticals’ VORANIGO gets FDA approval.
Read MorePosted by Andy Lundin | Oct 16, 2024 | Diagnostic Technologies, POC Instruments |
A handheld, sound-based diagnostic system can deliver precise blood test results in under 70 minutes from a finger prick.
Read MorePosted by Chris Wolski | Oct 14, 2024 | Cervical (HPV) |
Labcorp’s adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
Read MorePosted by Chris Wolski | Oct 11, 2024 | Molecular Diagnostic Analyzers |
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Read More